Abstract
Get full access to this article
View all access options for this article.
References
1.
Moroni
G
Ponticelli
C
. Rapidly progressive crescentic glomerulonephritis: early treatment is a must . Autoimmun Rev . 2014 ;13 :723 -729 .
2.
Beck
LH
Jr
Salant
DJ
. Glomerular and tubulointerstitial diseases . Prim Care . 2008 ;35 :265 -296 .
3.
Little
MA
Pusey
CD
. Rapidly progressive glomerulonephritis: current and evolving treatment strategies . J Nephrol . 2004 ;17 (suppl 8 ):S10 -S19 .
4.
Jennette
JC
. Rapidly progressive crescentic glomerulonephritis . Kidney Int . 2003 ;63 :1164 -1177 .
5.
West
SC
Arulkumaran
N
Ind
PW
Pusey
CD
. Pulmonary-renal syndrome: a life threatening but treatable condition . Postgrad Med J . 2013 ;89 :274 -283 .
6.
Dammacco
F
Battaglia
S
Gesualdo
L
Racanelli
V
. Goodpasture’s disease: a report of ten cases and a review of the literature . Autoimmun Rev . 2013 ;12 :1101 -1108 .
7.
Salama
AD
Levy
JB
Lightstone
L
Pusey
CD
. Goodpasture’s disease . Lancet . 2001 ;358 :917 -920 .
8.
Greco
A
Rizzo
MI
De Virgilio
A
. Goodpasture’s syndrome: a clinical update . Autoimmun Rev . 2015 ;14 :246 -253 .
9.
Bayat
A
Kamperis
K
Herlin
T
. Characteristics and outcome of Goodpasture’s disease in children . Clin Rheumatol . 2012 ;31 :1745 -1751 .
10.National Guideline Committee . KDIGO clinical practice guideline for glomerulonephritis . http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-GN-Guideline.pdf. Accessed April 1, 2016 .